Apogee Therapeutics Stock (NASDAQ: APGE) stock price, news, charts, stock research, profile.
You can purchase shares of Apogee Therapeutics (NASDAQ:APGE) through any online brokerage.
Other companies in Apogee Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), 89bio (NASDAQ:ETNB), Centessa Pharmaceuticals (NASDAQ:CNTA), Arcutis Biotherapeutics (NASDAQ:ARQT) and Protagonist Therapeutics (NASDAQ:PTGX).
Apogee Therapeutics has a consensus price target of $78.67.
The stock price for Apogee Therapeutics (NASDAQ: APGE) is $34.4 last updated February 21, 2025 at 6:57 PM EST.
There are no upcoming dividends for Apogee Therapeutics.
Apogee Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Apogee Therapeutics.
Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.